A detailed history of Gts Securities LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gts Securities LLC holds 38,300 shares of AZN stock, worth $2.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
38,300
Previous 42,300 9.46%
Holding current value
$2.47 Million
Previous $3.3 Million 9.52%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $317,413 - $362,746
-4,140 Reduced 41.33%
5,876 $457,000
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $3.99 Million - $4.82 Million
-59,685 Reduced 85.63%
10,016 $781,000
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $4.25 Million - $4.85 Million
69,701 New
69,701 $4.72 Million
Q3 2023

Nov 15, 2023

BUY
$64.85 - $71.7 $2.19 Million - $2.42 Million
33,735 New
33,735 $2.28 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.